[go: up one dir, main page]

Guerrini et al., 1997 - Google Patents

Address and message sequences for the nociceptin receptor: A structure− activity study of nociceptin-(1− 13)-peptide amide

Guerrini et al., 1997

Document ID
1393414672126216277
Author
Guerrini R
Calo' G
Rizzi A
Bianchi C
Lazarus L
Salvadori S
Temussi P
Regoli D
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

Nociceptin (NC) and some of its fragments as well as nociceptin-(1− 13)-peptide amide [NC (1− 13)-NH2] and a series of its analogues were prepared and tested in the mouse vas deferens in an attempt to identify the sequences involved in the activation (message) and in …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Similar Documents

Publication Publication Date Title
Guerrini et al. Address and message sequences for the nociceptin receptor: A structure− activity study of nociceptin-(1− 13)-peptide amide
Grieco et al. D-amino acid scan of γ-melanocyte-stimulating hormone: Importance of Trp8 on human MC3 receptor selectivity
Calo' et al. Structure− Activity Study of the Nociceptin (1− 13)-NH2 N-Terminal Tetrapeptide and Discovery of a Nociceptin Receptor Antagonist
Balboni et al. Evaluation of the Dmt− Tic pharmacophore: conversion of a potent δ-Opioid receptor antagonist into a potent δ agonist and ligands with mixed properties
Guerrini et al. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor
Wilczynski et al. Identification of putative agouti-related protein (87− 132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands
Negri et al. Dermorphin and deltorphin glycosylated analogues: synthesis and antinociceptive activity after systemic administration
Gilon et al. A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis
Haskell-Luevano et al. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c [Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors
Arttamangkul et al. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the “address” sequence
Rajeswaran et al. Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist
Tomatis et al. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides
Agnes et al. Structure− activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors
Ericson et al. Discovery of a β-hairpin octapeptide, c [Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], mimetic of agouti-related protein (87–132)[AGRP (87–132)] with equipotent mouse melanocortin-4 receptor (mMC4R) antagonist pharmacology
Miranda et al. Constrained corticotropin-releasing factor antagonists with i-(i+ 3) Glu− Lys bridges
Guerrini et al. Structure− activity studies of the Phe4 residue of nociceptin (1− 13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor
Rajeswaran et al. N-methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity
Zhou et al. Design of MC1R selective γ-MSH analogues with canonical amino acids leads to potency and pigmentation
Doering et al. Discovery of mixed pharmacology melanocortin-3 agonists and melanocortin-4 receptor tetrapeptide antagonist compounds (TACOs) based on the sequence Ac-Xaa1-Arg-(pI) DPhe-Xaa4-NH2
Tran et al. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues
Lee et al. Design and synthesis of novel hydrazide-linked bifunctional peptides as δ/μ opioid receptor agonists and CCK-1/CCK-2 receptor antagonists
Ericson et al. Structure–Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor
Kokko et al. In vitro analysis of stable, receptor-selective neurotensin [8− 13] analogues
Guerrini et al. N-and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands
Lung et al. Effects of Modifications of Residues in Position 3 of Dynorphin A (1− 11)-NH2 on κ Receptor Selectivity and Potency